A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
Clinical trial NCT05069896 · COMPLETED
Trial details
- NCT number
- NCT05069896
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2022-06-22
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.